Clinical and pharmacological studies of methotrexate-minimal leucovorin rescue plus fluorouracil. 1982

M C Wiemann, and F J Cummings, and H G Kaplan, and E N Spremulli, and C H Doolittle, and P Calabresi

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D002955 Leucovorin The active metabolite of FOLIC ACID. Leucovorin is used principally as an antidote to FOLIC ACID ANTAGONISTS. Calcium Leucovorin,Citrovorum Factor,Folinic Acid,N(5)-Formyltetrahydrofolate,5-Formyltetrahydrofolate,5-Formyltetrahydropteroylglutamate,Calcium Folinate,Folinic Acid-SF,Leucovorin, (D)-Isomer,Leucovorin, (DL)-Isomer,Leucovorin, (R)-Isomer,Leucovorin, Calcium (1:1) Salt,Leucovorin, Calcium (1:1) Salt, (DL)-Isomer,Leucovorin, Calcium (1:1) Salt, Pentahydrate,Leucovorin, Monosodium Salt,Leukovorin,Leukovorum,Wellcovorin,5 Formyltetrahydrofolate,5 Formyltetrahydropteroylglutamate,Acid, Folinic,Factor, Citrovorum,Folinate, Calcium,Folinic Acid SF,Leucovorin, Calcium,Monosodium Salt Leucovorin
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU

Related Publications

M C Wiemann, and F J Cummings, and H G Kaplan, and E N Spremulli, and C H Doolittle, and P Calabresi
March 1979, Cancer research,
M C Wiemann, and F J Cummings, and H G Kaplan, and E N Spremulli, and C H Doolittle, and P Calabresi
December 1996, Gan to kagaku ryoho. Cancer & chemotherapy,
M C Wiemann, and F J Cummings, and H G Kaplan, and E N Spremulli, and C H Doolittle, and P Calabresi
August 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
M C Wiemann, and F J Cummings, and H G Kaplan, and E N Spremulli, and C H Doolittle, and P Calabresi
August 1978, Cancer nursing,
M C Wiemann, and F J Cummings, and H G Kaplan, and E N Spremulli, and C H Doolittle, and P Calabresi
June 1991, British journal of cancer,
M C Wiemann, and F J Cummings, and H G Kaplan, and E N Spremulli, and C H Doolittle, and P Calabresi
November 1974, JAMA,
M C Wiemann, and F J Cummings, and H G Kaplan, and E N Spremulli, and C H Doolittle, and P Calabresi
March 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
M C Wiemann, and F J Cummings, and H G Kaplan, and E N Spremulli, and C H Doolittle, and P Calabresi
July 1973, Cancer research,
M C Wiemann, and F J Cummings, and H G Kaplan, and E N Spremulli, and C H Doolittle, and P Calabresi
October 2008, Gan to kagaku ryoho. Cancer & chemotherapy,
M C Wiemann, and F J Cummings, and H G Kaplan, and E N Spremulli, and C H Doolittle, and P Calabresi
January 1991, The Journal of rheumatology,
Copied contents to your clipboard!